New oral drug cuts Alzheimer’s cognitive decline by 50% in early study
Indiana University and Pharmatrophix presented a new analysis at the Alzheimer’s Association International Conference showing LM11A-31, an oral p75NTR modulator, may help preserve brain functional-network connectivity in people with mild-to-moderate Alzheimer’s disease, according to the company. The
<p>Indiana University and Pharmatrophix presented a new analysis at the Alzheimer’s Association International Conference showing LM11A-31, an oral p75NTR modulator, may help preserve brain functional-network connectivity in people with mild-to-moderate Alzheimer’s disease, according to the company. The</p>